Schroder Investment Management Group
ONC

Schroder Investment Management Group’s BeOne Medicines Ltd ONC Stock Holding History

Schroder Investment Management Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.6M Sell
29,641
-19,703
-40% -$5.81M 0.01% 698
2026
Q1 		$14M Buy
49,344
+9,511
+24% +$3.08M 0.01% 594
2025
Q4 		$12.1M Buy
39,833
+27,783
+231% +$9.09M 0.01% 607
2025
Q3 		$4.01M Sell
12,050
-18,019
-60% -$5.47M ﹤0.01% 808
2025
Q2 		$7.28M Buy
30,069
+11,462
+62% +$2.81M 0.01% 692
2025
Q1 		$4.98M Sell
18,607
-67,722
-78% -$15.8M 0.01% 758
2024
Q4 		$15.9M Buy
86,329
+54,030
+167% +$11M 0.02% 567
2024
Q3 		$7.05M Sell
32,299
-51,989
-62% -$9.35M 0.01% 731
2024
Q2 		$12M Buy
84,288
+10,427
+14% +$1.61M 0.01% 605
2024
Q1 		$11.6M Buy
73,861
+61,161
+482% +$9.85M 0.01% 623
2023
Q4 		$2.29M Buy
+12,700
New +$2.3M ﹤0.01% 888
2022
Q1 		– Sell
-273
Closed -$6K – 1617
2021
Q4 		$6K Sell
273
-276
-50% -$93.2K ﹤0.01% 1396
2021
Q3 		$15K Buy
549
+507
+1,207% +$166K ﹤0.01% 1440
2021
Q2 		$14K Sell
42
-2,997
-99% -$993K ﹤0.01% 1467
2021
Q1 		$1.06M Buy
+3,039
New +$1.01M ﹤0.01% 1148
2020
Q4 		– Sell
-145
Closed -$41K – 1513
2020
Q3 		$41K Buy
+145
New +$34.1K ﹤0.01% 1273
2020
Q2 		– Sell
-83
Closed -$12K – 1354
2020
Q1 		$12K Buy
+83
New +$13K ﹤0.01% 1277
2018
Q2 		– Sell
-2,800
Closed -$470K – 1332
2018
Q1 		$470K Buy
+2,800
New +$379K ﹤0.01% 1064

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Schroder Investment Management Group's ONC Position: Q2 2026 in Review

Schroder Investment Management Group reduced its BeOne Medicines Ltd (ONC) stake by 40% in Q2 2026, selling an estimated $5.81M and leaving 29,641 shares worth $8.6M. The position accounts for 0.01% of the portfolio, ranked #698.

Schroder Investment Management Group first reported a position in ONC in Q1 2018 and has held it in 18 quarters since. The position peaked at $15.9M in Q4 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Schroder Investment Management Group held 29,641 shares of BeOne Medicines Ltd worth $8.6M as of Q2 2026.
  • Schroder Investment Management Group sold 19,703 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.81M.
  • BeOne Medicines Ltd made up 0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #698 holding.
  • Schroder Investment Management Group first reported a position in BeOne Medicines Ltd in Q1 2018 and has held it in 18 quarters since.
  • Schroder Investment Management Group's BeOne Medicines Ltd position peaked at $15.9M in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.